Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

NCT00357279 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: denufosol tetrasodium (INS37217) Inhalation Solution
DRUG: Placebo - 0.9% w/v sodium chloride solution

Sponsor

Merck Sharp & Dohme LLC